Predictability of success of endoscopic vesicoureteral reflux treatment utilizing clinical risk factors and intraoperative injection characteristics
- 5 January 2025
- journal article
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 21 (5) , 1336-1341
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Proprietary non-animal stabilized hyaluronic acid/dextranomer gel (NASHA/Dx) for endoscopic treatment of grade IV vesicoureteral reflux: Long-term observational studyJournal of Pediatric Urology, 2020
- Factores implicados en el fracaso tardío del tratamiento endoscópico del reflujo vesicoureteralActas Urológicas Españolas, 2018
- Endoscopic injection for primary vesicoureteric reflux: Predictors of resolution and long term efficacyJournal of Pediatric Surgery, 2017
- STING versus HIT technique of endoscopic treatment for vesicoureteral reflux: A systematic review and meta-analysisJournal of Pediatric Surgery, 2016
- VUR timing on VCUG as a predictive factor of VUR resolution after endoscopic therapyJournal of Pediatric Urology, 2016
- Ultrasonographic mound height as predictor of vesicoureteral reflux resolution after endoscopic treatment in childrenJournal of Pediatric Surgery, 2016
- Is routine voiding cystourethrogram necessary following double hit for primary vesicoureteral reflux?Journal of Pediatric Urology, 2015
- Endoscopic treatment for vesicoureteral reflux: How important is technique?Journal of Pediatric Urology, 2013
- Vesicoureteral Reflux: Current Trends in Diagnosis, Screening, and TreatmentEuropean Urology, 2012
- Are there predictive factors for the outcome of endoscopic treatment of grade III–V vesicoureteral reflux with dextranomer/hyaluronic acid in children?Pediatric Surgery International, 2007